Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Other1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT03982992Phase 2Withdrawn
Allogeneic Donor Lymphocyte Infusions Combined With Blinatumomab
Acute Lymphoblastic LeukemiaAcute Lymphoblastic Leukemia in RemissionAcute Lymphoblastic Leukemia, Adult+2 more
PrincipalinvestigatorStart date: 2019-06-01

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Sascha Haubner, MD

LMU Klinikum

Similar
1 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaAcute Lymphoblastic Leukemia, AdultAcute Lymphoblastic Leukemia in Remission+2 more

Worked with same sponsors:

AmgenLudwig-Maximilians - University of Munich
Collaborated on 1 trial
Similarity Score54%

Jae Park, MD

Memorial Sloan Kettering Cancer Center

Related
17 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaB-cell Acute Lymphoblastic Leukemia

Worked with same sponsors:

Amgen
Similarity Score12%

Elias Jabbour, MD

M.D. Anderson Cancer Center

Related
15 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaB-cell Acute Lymphoblastic Leukemia

Worked with same sponsors:

Amgen
Similarity Score12%

Elias Jabbour

M.D. Anderson Cancer Center

Related
15 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaAcute Lymphoblastic Leukemia in Remission

Worked with same sponsors:

Amgen
Similarity Score12%

xiaowen tang, Ph.D

The First Affiliated Hospital of Soochow University

Related
11 trials

Shared therapeutic areas:

B-cell Acute Lymphoblastic LeukemiaPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Similarity Score12%

Beata Holkova, MD

Massey Cancer Center

Related
3 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Similarity Score6%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Similarity Score6%

Partow Kebriaei, MD

M.D. Anderson Cancer Center

Related
10 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Worked with same sponsors:

Amgen
Similarity Score6%

Ryotaro Nakamura

City of Hope Medical Center

Related
10 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Similarity Score6%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Similarity Score6%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT03982992Phase 2PrincipalInvestigator

Allogeneic Donor Lymphocyte Infusions Combined With Blinatumomab

Acute Lymphoblastic LeukemiaAcute Lymphoblastic Leukemia in RemissionAcute Lymphoblastic Leukemia, Adult+2 more
Withdrawn

All 1 trials loaded